Gubentongluo decoction alleviates NLRP3 inflammasome in IgAN cell model

References

• An HJ, Nugroho A, Song BM, Park HJ. 2015. Isoeugenin, a novel nitric oxide synthase inhibitor isolated from the rhizomes of Imperata cylindrica. Molecules. 20(12):21336–21345. doi:10.3390/molecules201219767.
   PubMed Web of Science ®Google Scholar
• Chan LY, Leung JC, Lai KN. 2004. Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure. Clin Exp Nephrol. 8(4):297–303. doi:10.1007/s10157-004-0324-9.
   Google Scholar
• Chen M, Wang H, Chen W, Meng G. 2011. Regulation of adaptive immunity by the NLRP3 inflammasome. Int Immunopharmacol. 11(5):549–554. doi:10.1016/j.intimp.2010.11.025.
   Web of Science ®Google Scholar
• Coppo R, Amore A, Peruzzi L, Vergano L, Camilla R. 2010. Innate immunity and IgA nephropathy. J Nephrol. 23(6):626–632.
   Web of Science ®Google Scholar
• Deng F, Zhang J, Li Y, Wang W, Hong D, Li G, Feng J. 2019. Hirudin ameliorates immunoglobulin A nephropathy by inhibition of fibrosis and inflammatory response. Renal Fail. 41(1):104–112. doi:10.1080/0886022X.2019.1583113.
   PubMed Web of Science ®Google Scholar
• Hahn WH, Cho BS, Kim SD, Kim SK, Kang S. 2009. Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy. Pediatr Nephrol. 24(7):1329–1336. doi:10.1007/s00467-009-1146-5.
   PubMed Web of Science ®Google Scholar
• Hua KF, Yang SM, Kao TY, Chang JM, Chen HL, Tsai YJ, Chen A, Yang SS, Chao LK, Ka SM. 2013. Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-kappaB/NLRP3 pathway. PLoS One. 8(10):e77794. doi:10.1371/journal.pone.0077794.
   PubMed Web of Science ®Google Scholar
• Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB. 2016. IgA nephropathy. Nat Rev Dis Primers. 2:16001. doi:10.1038/nrdp.2016.1.
   PubMed Web of Science ®Google Scholar
• Li WW, Huang D, Shen PC, WU Q, SUN C, WANG XX, HE LQ. 2017. Effects of Gubentongluo formula on oxidative stress reflected by expressions of PPARα and L-FABP in mice with IgA nephropathy. J Sichuan Univ. 48(2):210–215.
   Google Scholar
• Lorenz G, Darisipudi MN, Anders HJ. 2014. Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis. Nephrol Dial Transplant. 29(1):41–48. doi:10.1093/ndt/gft332.
   PubMed Web of Science ®Google Scholar
• Moroni G, Belingheri M, Frontini G, Tamborini F, Messa P. 2019. Immunoglobulin A nephropathy. Recurrence after renal transplantation. Front Immunol. 10:1332. doi:10.3389/fimmu.2019.01332.
   Web of Science ®Google Scholar
• Mulay SR, Evan A, Anders HJ. 2014. Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease. Nephrol Dial Transplant. 29(3):507–514. doi:10.1093/ndt/gft248.
   PubMed Web of Science ®Google Scholar
• Park SJ, Kim YW, Park MK, Byun SH, Kim SC, Lee JR. 2016. Anti-inflammatory steroid from Phragmitis rhizoma modulates LPS-mediated signaling through inhibition of NF-kappaB pathway. Inflammation. 39(2):727–734. doi:10.1007/s10753-015-0299-6.
   Web of Science ®Google Scholar
• Peng W, Pei GQ, Tang Y, Tan L, Qin W. 2019. IgA1 deposition may induce NLRP3 expression and macrophage transdifferentiation of podocyte in IgA nephropathy. J Transl Med. 17(1):406. doi:10.1186/s12967-019-02157-2.
   Web of Science ®Google Scholar
• Reinhart D, Weik R, Kunert R. 2012. Recombinant IgA production: single step affinity purification using camelid ligands and product characterization. J Immunol Methods. 378(1–2):95–101. doi:10.1016/j.jim.2012.02.010.
   Web of Science ®Google Scholar
• Shahzad M, Shabbir A, Wojcikowski K, Wohlmuth H, Gobe GC. 2016. The antioxidant effects of Radix Astragali (Astragalus membranaceus and related species) in protecting tissues from injury and disease. Curr Drug Targets. 17(12):1331–1340. doi:10.2174/1389450116666150907104742.
   Web of Science ®Google Scholar
• Shao X, Li B, Cao L, Liang L, Yang J, Wang Y, Feng S, Wang C, Weng C, Shen X, et al. 2017. Evaluation of crescent formation as a predictive marker in immunoglobulin A nephropathy: a systematic review and meta-analysis. Oncotarget. 8(28):46436–46448. doi:10.18632/oncotarget.17502.
   Google Scholar
• Shen P, Shen J, Sun C, Yang X, He L. 2016. A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy. BMC Complement Altern Med. 16(1):312. doi:10.1186/s12906-016-1268-9.
   Google Scholar
• Shen PC, He LQ. 2016. Effect of ‘Gubentongluo formula’ on the IgA class switch recombination of B Lymohocytes in Peyer's patches in mice with IgA nephropathy. J Sichuan Univ Med Sci Ed. 47(3):337–341.
   Google Scholar
• Shi B, Ni Z, Cao L, Zhou M, Mou S, Wang Q, Zhang M, Fang W, Yan Y, Qian J. 2012. Serum IL-18 is closely associated with renal tubulointerstitial injury and predicts renal prognosis in IgA nephropathy. Mediat Inflamm. 2012:728417. doi:10.1155/2012/728417.
   PubMed Web of Science ®Google Scholar
• Swanson KV, Deng M, Ting JP. 2019. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 19(8):477–489. doi:10.1038/s41577-019-0165-0.
   PubMed Web of Science ®Google Scholar
• Tsai YL, Hua KF, Chen A, Wei CW, Chen WS, Wu CY, Chu CL, Yu YL, Lo CW, Ka SM. NLRP3 inflammasome: pathogenic role and potential therapeutic target for IgA nephropathy. Sci Rep. 7:41123. doi:10.1038/srep41123.
   Web of Science ®Google Scholar
• Tschopp J, Schroder K. 2010. NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production? Nat Rev Immunol. 10(3):210–215. doi:10.1038/nri2725.
   PubMed Web of Science ®Google Scholar
• Xiong J, Wang Y, Shao N, Gao P, Tang H, Su H, Zhang C, Meng XF. 2015. The expression and significance of NLRP3 inflammasome in patients with primary glomerular diseases. Kidney Blood Press Res. 40(4):344–354. doi:10.1159/000368511.
   PubMed Web of Science ®Google Scholar
• Yang SM, Ka SM, Hua KF, Wu TH, Chuang YP, Lin YW, Yang FL, Wu SH, Yang SS, Lin SH, et al. 2013. Antroquinonol mitigates an accelerated and progressive IgA nephropathy model in mice by activating the Nrf2 pathway and inhibiting T cells and NLRP3 inflammasome. Free Radical Biol Med. 61:285–297. doi:10.1016/j.freeradbiomed.2013.03.024.
   PubMed Web of Science ®Google Scholar